Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (93 ops.)
Latest filing published 21 Jul 2025 for Empery Digital Inc., €257k.
Filing timeline
BuySaleIan C. Read
Insider track record
Disclosed buys
0
Disclosed sells
93
Signal history
Ian C. Read: trading record in brief
Ian C. Read, Chairman & CEO of Pfizer Inc (127 filings), appears in 136 filings between February 26, 2016 and July 21, 2025, with a few Director seats at Viatris Inc, DXC Technology Co, Kimberly Clark Corp and Empery Digital Inc. The 93 sales, all at Pfizer Inc, weigh EUR 58.1 million, with a median of EUR 141,768. The largest, EUR 8,046,134, is from May 9, 2016, ahead of August 31, 2017 (EUR 4,030,552) and March 4, 2019 (EUR 2,729,552). No purchase is in the record; it holds 25 grants and 14 option exercises.
The volume is concentrated in 2018 (46 filings) and 2019 (60), against 2 to 3 a year from 2020 to 2022. No filing falls in the last 12 months.
At Pfizer Inc, 85 of Read's trades fall within 30 days of a trade by Alexander R. Mackenzie and 85 of one by Sally Susman, all in the same direction, followed by Mikael Dolsten (58).
Companies and markets linked to Ian C. Read
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations136 total
30,000 shares@ US$10.00100.0% of flowCommon StockSEC:0001683168-25-005265:0
166 shares0Common StockSEC:0000899243-22-011992:0
335 shares0Common StockSEC:0000899243-22-009548:1
13,996 shares0Common StockSEC:0000899243-22-009548:0
12,700 shares0Common StockSEC:0001688568-21-000072:0
700 shares0Common StockSEC:0001225208-21-002132:0
700 shares0Common StockSEC:0001225208-21-002132:1
23,200 shares0Common StockSEC:0001688568-20-000070:0
12,900 shares0Common StockSEC:0001688568-20-000025:0
3,694 shares@ US$43.390.1% of flowCommon StockSEC:0001225208-19-004781:29
100 shares@ US$43.110.0% of flowCommon StockSEC:0001225208-19-004781:0
200 shares@ US$43.230.0% of flowCommon StockSEC:0001225208-19-004781:1
300 shares@ US$43.190.0% of flowCommon StockSEC:0001225208-19-004781:2
300 shares@ US$43.100.0% of flowCommon StockSEC:0001225208-19-004781:3
400 shares@ US$43.380.0% of flowCommon StockSEC:0001225208-19-004781:4
400 shares@ US$43.200.0% of flowCommon StockSEC:0001225208-19-004781:5
425 shares@ US$43.250.0% of flowCommon StockSEC:0001225208-19-004781:6
513 shares@ US$43.570.0% of flowCommon StockSEC:0001225208-19-004781:7
600 shares@ US$43.270.0% of flowCommon StockSEC:0001225208-19-004781:8
700 shares@ US$43.220.0% of flowCommon StockSEC:0001225208-19-004781:9
802 shares@ US$43.150.0% of flowCommon StockSEC:0001225208-19-004781:10
1,200 shares@ US$43.130.0% of flowCommon StockSEC:0001225208-19-004781:11
1,200 shares@ US$43.090.0% of flowCommon StockSEC:0001225208-19-004781:12
1,604 shares@ US$43.160.1% of flowCommon StockSEC:0001225208-19-004781:13
1,720 shares@ US$43.310.1% of flowCommon StockSEC:0001225208-19-004781:14
25 of 136 declarations
